EricBartonSuhlerMDMPH

Ophthalmology • Portland, OR

Retinal Disease, Uveitis

Professor, Ophthalmology and Public Health, Oregon Health and Science University, and Chief of Ophthalmology, VA Portland Health Care System

Join to view full profile

Dr. Suhler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Suhler's full profile

Already have an account?

Office
3375 Sw Terwilliger Blvd
Portland, OR 97239
Phone+1 503-494-5023

Fax+1 503-494-6875

Education & Training

Oregon Health & Science UniversityMPH, Epidemiology and Biostatistics, Outstanding Thesis, 1999 - 2007
Oregon Health & Science University (OHSU Health)Residency, Ophthalmology, 1996 - 2000
University of HawaiiInternship, Internal Medicine, 1995 - 1996
University of Texas Southwestern Medical SchoolClass of 1995

Certifications & Licensure

OR State Medical License 2002 - 2025
MD State Medical License 2000 - 2003
HI State Medical License 1995 - 1996
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

A Clinical Trial of Infliximab for Uveitis Start of enrollment: 2001 Aug 01
Completed
Not Applicable
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation Start of enrollment: 2007 Jan 01
Completed
Phase 1, Phase 2
Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis Start of enrollment: 2008 Jan 01
Completed
Phase 2
Apremilast in the Treatment of Uveitis Start of enrollment: 2009 Nov 01
Terminated
Phase 1, Phase 2
Abatacept in the Treatment of Uveitis Start of enrollment: 2012 Jan 01
Completed
Phase 2
Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis Start of enrollment: 2013 Nov 01
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

41 citations
Adalimumab for Ocular Inflammation
Khayyam Durrani, John H. Kempen, Gui-Shuang Ying, R. Oktay Kaçmaz, Pichaporn Artornsombudh
Ocular Immunology and Inflammation. 2017-05-04
238 citations
A Prospective Trial of Infliximab Therapy for Refractory Uveitis: Preliminary Safety and Efficacy Outcomes
Eric B. Suhler, Justine R. Smith, Michael S. Wertheim, Andreas K. Lauer, Daryl E. Kurz
Archives of Ophthalmology. 2005-07-01
379 citations
Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe, Andrew D. Dick, Antoine P. Brézin, Quan Dong Nguyen, Jennifer E. Thorne
The New England Journal of Medicine. 2016-09-07

Press Mentions

NEW PRODUCT APPLICATIONS: Yutiq Implant for Chronic Noninfectious Posterior-Segment UveitisApril 1st, 2019

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Other Languages

Spanish